Item 9 Labs EBIT

As of the most recent data (June 2023), INLB shows a EBIT of $-22M. That compares with $-14M in the prior-year period — down 51.4% year over year. That is below the sector sector average of $2.5T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INLB's EBIT is now $-22M (was $-14M) — a 51.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Item 9 Labs is outperforming or lagging.

The its sector sector average EBIT is about $2.5T. Item 9 Labs is at $-22M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how INLB stacks up against individual peers as well.

Tracking INLB's ebit over time shows whether Item 9 Labs is scaling, shrinking, or reshaping that part of the business. The current reading is $-22M That compares with $-14M in the prior-year period — down 51.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Item 9 Labs's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-22M) with ownership activity and broader fundamentals.